Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: A prospective randomized study comparing labetalol with alpha methyldopa

Archives of Gynecology and Obstetrics

Volumn 285, Issue 6, 2012, Pages 1553-1562

  Molvi, Shaba N ^a   Mir, Shahida ^a   Rana, Vikram S ^b   Jabeen, Farhat ^a   Rauoof Malik, A ^b  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Labetalol; Methyldopa; Pre eclampsia; Pregnancy induced hypertension

Indexed keywords

LABETALOL; METHYLDOPA;

ADULT; ARTICLE; BRADYCARDIA; CESAREAN SECTION; CONGENITAL MALFORMATION; CONTROLLED STUDY; DISEASE SEVERITY; DROWSINESS; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL MORTALITY; NAUSEA; NOSE CONGESTION; ORTHOSTATIC HYPOTENSION; PERINATAL DEATH; PREGNANCY OUTCOME; PREMATURE LABOR; PROSPECTIVE STUDY; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SMALL FOR DATE INFANT; TREATMENT OUTCOME; VOMITING;

ADULT; ANTIHYPERTENSIVE AGENTS; CESAREAN SECTION; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INCIDENCE; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LABETALOL; METHYLDOPA; PREGNANCY; PREMATURE BIRTH; PROTEINURIA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864465524     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-2205-2     Document Type: Article

References (43)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183:S1-S22
2. Sibai BM (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102(1):181-192
3. Seely EW, Lindheimer MD (2003) Pathophysiology of pre-eclampsia. In: Izzi JL Jr, Black HR (eds) Hypertension Primer, 3rd edn. American Heart Association, Dallas, pp 160-163
4. Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365(9461):785-799
5. Rey E, LeLorier J, Burgess E et al (1997) Report of the Canadian Hypertension Society Consensus Conference:3. Pharmacological treatment of hypertensive disorders in pregnancy. Can Med Assoc J 157(9):1245-1254
6. Vreeburg SA, Jacobs DJ, Dekker GA et al (2004) Hypertension during pregnancy in South Australia, part 2: risk factors for adverse maternal and/or perinatal outcome-results of multivariable analysis. Aus N Z J Obstet Gynaecol 44(5):410-418
7. Roberts CL, Algert CS, Morris JM et al (2005) Hypertensive disorders in pregnancy: a population-based study. Med J Aust 182(7):332-335
8. Duley L (1992) Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Carribean. Br J Obstet Gynaecol 99:547-553
9. Sibai BM, Eclampsia VI (1990) Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 163:1049-1054
10. ACOG Committee on Practice Bulletins-Obstetrics (2002) ACOG practice bulletin. Diagnosis and management of pre-eclampsia and eclampsia. Number 33 Obstet Gynecol 9(1):159
11. Blake S, MacDonald D (1991) The prevention of the maternal manifestations of preeclampsia by intensive antihypertensive treatment. Br J Obstet Gynecol 98(3):244-248
12. Phippard AF, Fischer WE, Horvath JS et al (1991) Early blood pressure control improves pregnancy outcome in primigravid women with mild hypertension. Med J Aust 154(6):378-382
13. Elhassan EM, Mirghani OA, Habour AB et al (2002) Methyldopa versus no drug treatment in the management of mild pre-eclampsia. East Afr Med J 79(4):172-175
14. Plouin PF, Breart G, Llado J et al (1990) A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension. Br J Obstet Gynecol 97(2):134-141
15. Magee LA, Elran E, Bull SB et al (2000) Risks and benefits of beta receptor blockers for pregnancy hypertension: Overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol 88:15-26
16. Pickles CJ, Broughton PF, Symonds EM (1992) A randomized placebo controlled trial of labetalol in he treatment of mild to moderate pregnancy induced hypertension. Br J Obstet Gynaecol 99(12):964-968
17. Magee LA, Ornstein MP, von Dadelszen P (1999) Management of hypertension in pregnancy. Br Med J 318:1332-1336
18. Podymow T, August P (2011) Antihypertensive drugs in pregnancy. Semin Nephrol 31:70-85
19. American College of Obstetricians and Gynecologists Technical Bulletin No. 219 (1996). Hypertension in Pregnancy. Int J Gynecol Obstet 53:175-183
20. Mabie WC (1999) Management of acute severe hypertension and encephalopathy. Clin Obstet Gynecol 42:519-531
21. Linton DM, Anthony J (1997) Critical care management of severe pre-eclampsia. Intensive Care Med 23:248-255
22. Khedun SM, Moodley J, Naicker T et al (1997) Drug management of hypertensive disorders of pregnancy. Pharmacol Ther 74:221-258
23. Lamming GD, Broughton Pipkin F, Symonds EM (1980) Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension. Clin Exp Hypertens 2(5):865-895
24. El-Qarmalawi AM, Morsy AH, Al-Fadly A et al (1995) Labetalol vs methyldopa in the treatment of pregnancy-induced hypertension. Int J Gynecol Obstet 49:125-130
25. Al Damluji SF, Al Khalidi A, Shaarbaf H (1982) A controlled comparison of the antihypertensive effects of labetalol and methyldopa. Pharmatherapeutica 3(2):133-139
26. Plouin PF, Breart G, Maillard F, Papiernik E, Relier JP (1988) Comparison of antihypertensive efficacy and prenatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. Br J Obstet Gynaecol 95(9):868-876
27. Magee LA, Duley L (2003) Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev (3):CD002863
28. Abalos E, Duley L, Steyn DW, et al (2001) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev (2):CD002252
29. Saudan P, Brown MA, Buddle ML et al (1998) Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol 105:1177-1184
30. Barton JR, O'Brien JM, Bergauer NK et al (2001) Mild gesta-tional hypertension remote from term: progression and outcome. Am J Obstet Gynecol 184:979-983
31. Davis GK, Mackenzie C, Brown MA et al (2007) Predicting transformation from gestational hypertension to preeclampsia in clinical practice: a possible role for 24 hour ambulatory blood pressure monitoring. Hypertens Pregnancy 26:77-87
32. Martin JN Jr, Thigpen BD, Moore RC, Rose CH, Cushman J, May W (2005) Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 105:246-254
33. Magee LA, Helewa M, Moutquin JM, van Dadelszen P, The Hypertension Guideline Committee (2008) Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. SOGC Clinical Practice Guideline, No. 206. J Obstet Gynaecol Can 30:S1-S48
34. Brown MA, Buddle ML (1996) Hypertension in pregnancy: maternal and fetal outcomes according to laboratory and clinical features. Med J Aust 165:360-365
35. Pickles CJ, Symonds EM, Broughton PF (1989) The fetal outcome in a randomized double blind controlled trial of labetalol versus placebo in pregnancy induced hypertension. Br J Obstet Gynaecol 96(1):38-43
36. Redman CW (1976) Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 2(7989):753-756
37. Weitz C, Khouzami V, Maxwell K, Johnson JW (1987) Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study. Int J Gynecol Obstet 25(1):35-40
38. Ray JG, Burrows RF, Burrows EA et al (2001) MOS HIP: McMaster outcome study of hypertension in pregnancy. Early Hum Dev 64(2):129-143
39. Abalos E, Duley L, Steyn D, Henderson-Smart D (2007) Anti-hypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev CD002252
40. Lardoux H, Blazquez G, Leperlier E, Gérard J (1988) Randomized, comparative study on the treatment of moderate arterial hypertension during pregnancy: methyldopa, acebutolol, labeta-lol. Arch Mal Coeur Vaiss 81:137-140
41. Gallery ED, Ross MR, Gyory AZ (1985) Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. Br Med J (Clin Res Ed) 291(6495): 563-566
42. Bryant AS, Seely EW, Cohen A et al (2005) Patterns of pregnancy-related hypertension in black and white women. Hypertens Pregnancy 24(3):281-290
43. Odell CD, Kotelchuck M, Chetty VK et al (2006) Maternal hypertension as a risk factor for low birth weight infants: comparison of Haitian and African-American women. Maternal Child Health J 10(1):39-46